编辑信息

Trinseo Offers Polymers, Specialty Engineered Solutions for Drug Delivery Devices

Company supports growth in self-administered healthcare

BERWYN, Pa. - Tuesday, July 11, 2017

Trinseo (NYSE: TSE), the global materials solution provider and manufacturer of plastics, latex binders and synthetic rubber, announced today that its Consumer Essential Markets (CEM) business unit will now support medical device and pharmaceutical manufacturers of Drug Delivery Devices with specialty engineered polymer solutions.

Typical drug delivery devices, also known as combination devices that can use Trinseo materials include auto injectors, insulin pens, asthma inhalers, prefilled syringes and wearable devices. The Company’s specialty compounded solutions are ideal for a wide range of applications – acrylonitrile butadiene styrene (ABS) for housings, polycarbonate (PC) for windows and needle shield caps, and polystyrene (PS) for secondary packaging.

Trinseo materials are offered under the brands CALIBRE™ Polycarbonate Resins, CALIBRE™ MEGARAD™ Polycarbonate Resins, EMERGE™ Advanced Resins, STYRON™ Polystyrene Resins and MAGNUM™ ABS Resins. They provide advantages which are critical to the market such as:

  • Appearance and color options
  • High impact resistance and toughness
  • High stiffness/modulus
  • Low residual monomer and oligomer levels
  • Radiation and Ethylene Oxide sterilization
  • Biocompatiblity tested resins and colors

Trinseo materials have been developed to meet the needs of manufacturers and molders - and they can be customized to meet exacting specifications. Trinseo medical grades have been biocompatibility tested and certain products are listed on a U.S. FDA Master Access File or Drug Master File.

The Company’s focus on drug delivery devices expands its support in the Medical Devices space which has included Single- and Multiple-Use Devices and Equipment Housings.  As healthcare professionals embrace self-administered care they need devices that not only are effective therapeutically but also offer their patients functionality, convenience, haptics and aesthetics. Polymers are a big part of the challenge and Trinseo, with a foundation in medical polymers, intends to offer the solution.

About Trinseo

Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber with a focus on delivering innovative, sustainable, and value-creating products that are intrinsic to our daily lives. Trinseo is dedicated to making a positive impact on society by partnering with like-minded stakeholders, and supporting the sustainability goals of our customers in a wide range of end-markets including automotive, consumer electronics, appliances, medical devices, packaging, footwear, carpet, paper and board, building and construction, and tires. Trinseo had approximately $3.0 billion in net sales in 2020, with 17 manufacturing sites around the world, and approximately 2,600 employees. For more information, please visit: www.trinseo.com.

Cautionary Note on Forward-Looking Statements

This press release may contain "forward-looking statements" including, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like "expect," "anticipate," "intend," "forecast," "outlook," "will," "may," "might," "see," "tend," "assume," "potential," "likely," "target," "plan," "contemplate," "seek," "attempt," "should," "could," "would" or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause such a difference include, but are not limited to those factors discussed in our Annual Report on Form 10-K, under Part I, Item 1A —"Risk Factors" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

编辑信息

接收盛禧奥独家内容

方便地通过电子邮件抢先了解新产品信息、公司新闻及其它盛禧奥资讯动态!